Bellevue Life Sciences Acquisition Profit Margin

As of the most recent data (June 2026), BLAC shows a profit margin of 671.56%. That compares with -994.91% in the prior-year period — up 167.5% year over year. That is above the sector sector average of 13.09%. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BLAC's profit margin is now 671.56% (was -994.91%) — a 167.5% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether Bellevue Life Sciences Acquisition is outperforming or lagging.

The its sector sector average profit margin is about 13.09%. Bellevue Life Sciences Acquisition is at 671.56%, which is higher that average. That is roughly 5030.9% above the sector mean. Use the comparison chart on this page to see how BLAC stacks up against individual peers as well.

That compares with -994.91% in the prior-year period — up 167.5% year over year. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Bellevue Life Sciences Acquisition with peers to see if the move is company-specific or sector-wide.

Besides this profit margin page, Stockcircle has Bellevue Life Sciences Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect profit margin (currently 671.56%) with ownership activity and broader fundamentals.